ClinicalTrials.gov record
Completed Phase 3 Interventional

A Clinical Study of Intravenous Immunoglobulin

ClinicalTrials.gov ID: NCT00468273

Public ClinicalTrials.gov record NCT00468273. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 8:53 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Clinical Study of Immune Globulin Intravenous (Human) Omr-IgG-am IGIV in Subjects With Primary Immune Deficiency Diseases

Study identification

NCT ID
NCT00468273
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
FFF Enterprises
Industry
Enrollment
57 participants

Conditions and interventions

Interventions

  • Immune Globulin Intravenous (Human) Omr-IgG-am IGIV Drug

Drug

Eligibility (public fields only)

Age range
3 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2006
Primary completion
Apr 30, 2009
Completion
Jul 31, 2009
Last update posted
Aug 10, 2014

2006 – 2009

United States locations

U.S. sites
8
U.S. states
6
U.S. cities
8
Facility City State ZIP Site status
Mattel Children's Hospital of UCLA Los Angeles California 90095-1752
1st Allergy and Clinical Research Center Centennial Colorado 80112
Allergy Associates of the Palm Beaches North Palm Beach Florida 33408
Rush University Medical Center Chicago Illinois 60612
Rainbow Babies and Children's Hospital Cleveland Ohio 44106
Optimed Research, LLC Columbus Ohio 43235
Pediatric Allergy Immunology Associates Dallas Texas 75230
Allergy, Asthma and Immunology Clinic PA Irving Texas 75230

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00468273, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 10, 2014 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00468273 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →